ALBERTO DANIEL SAUCEDO CAMPOS

Dr. ALBERTO DANIEL SAUCEDO CAMPOS

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2025 in Cancers
Verified
Journal Article
Open access
PDF file
EBEduardo Bautista-Sebastián
Eduardo Bautista-Sebastián
VCVíctor Adrián Cortés-Morales
Víctor Adrián Cortés-Morales
GFGUADALUPE FAJARDO
GUADALUPE FAJARDO
AMAlberto Monroy-García
Alberto Monroy-García
MCMarta Elena Castro-Manrreza
Marta Elena Castro-Manrreza
JMJuan Montesinos
Juan Montesinos
Background/Objectives: Macrophages with the M2 phenotype are an immune population with great relevance for tumor development. We have previously demonstrated that mesenchymal stromal cells (MSCs) from cervical cancer (CeCa-MSCs) enhance the immunomodulatory activity of CeCa cells on T lymphocytes; however, the effect of these cells on the ability of tumor cells to polarize macrophages had not been evaluated to date. Methods: To address this, we set out to analyze the effect of normal cervix (NCx) and CeCa-MSCs interacting with CeCa tumor cells (TCs) to polarize macrophages in a coculture system. Results: Our results show that macrophages from TC/NCx-MSC cocultures decreased CD163 expression. In turn, we observed that macrophages from TC/CeCa-MSC cocultures, in contrast to those in the presence of TCs/NCx-MSCs, increased the intracellular production of IDO, IL-4, and IL-10; decreased T lymphocyte proliferation; and increased the presence of soluble IL-10. Interestingly, coculture in the presence of TCs/NCx-MSCs decreased the capacity of macrophages to generate regulatory T lymphocyte populations, as well as their phagocytic capacity, and increased IL-6 secretion, unlike the coculture of macrophages in the presence of TCs/CeCa-MSCs. Our results show that TCs/CeCa-MSCs in cocultures, unlike TCs/NCx-MSCs, have a greater capacity to polarize macrophages to an M2 phenotype and that such macrophages have a greater immunosuppressive potential. Conclusions: This in vitro study suggests that intracellular communication between MSCs and tumor cells in CeCa may promote tumor growth through the polarization of macrophages with increased immunosuppressive activity.

31 July 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
MRMiguel Leonardo Méndez Rodríguez
Miguel Leonardo Méndez Rodríguez
APAlberto Ponciano-Gómez
Alberto Ponciano-Gómez
MCMyriam Campos-Aguilar
Myriam Campos-Aguilar
WTWilfrido David Tapia-Sánchez
Wilfrido David Tapia-Sánchez
CDCarlos Leonardo Duarte-Martínez
Carlos Leonardo Duarte-Martínez
VGVíctor Hugo Rosales García
Víctor Hugo Rosales García
Background: During the COVID-19 pandemic, identifying reliable biomarkers for predicting disease severity and patient outcomes in unvaccinated individuals is essential. This study evaluates the efficacy of key hematological markers, including leukocyte and neutrophil counts, Neutrophil-to-Lymphocyte Ratio (NLR), and cytokine profiles (IL-6, INF-γ, TNF-α, IL-17A, CCL2, and CXCL10) for predicting the necessity for mechanical ventilation and assessing survival probabilities. Methods: We conducted an in-depth analysis on a cohort of COVID-19 patients, emphasizing the relationship between NLR, cytokine profiles, and clinical outcomes, utilizing routine leukocyte counting and cytokine quantification by flow cytometry. Results: Elevated leukocyte and neutrophil counts, increased NLR, and significant cytokine elevations such as IL-6 and IL-10 were strongly associated with the need for mechanical ventilation, reflecting a pronounced systemic inflammatory response indicative of severe disease outcomes. Conclusion: Integrating hematological markers, particularly NLR and cytokine profiles, is crucial in predicting mechanical ventilation needs and survival in non-vaccinated COVID-19 patients. Our findings provide critical insights into the pathophysiology of COVID-19, supporting the development of more targeted clinical interventions and potentially informing future strategies for managing infectious disease outbreaks.

Verified
Journal Article
Open access
PDF file
ACALBERTO DANIEL SAUCEDO CAMPOS
ALBERTO DANIEL SAUCEDO CAMPOS
MCMaria Jose Lopez Chee
Maria Jose Lopez Chee
MCMyriam Campos-Aguilar
Myriam Campos-Aguilar
WTWilfrido David Tapia-Sánchez
Wilfrido David Tapia-Sánchez
SOSandra Olivas-Quintero
Sandra Olivas-Quintero
APAlberto Ponciano-Gómez
Alberto Ponciano-Gómez
Flow cytometric immunophenotyping is essential for the diagnosis and immunologic classification of B-cell acute lymphoblastic leukemia in children and is traditionally performed using bone marrow aspirates, an invasive procedure that may be delayed or unavailable in certain clinical contexts. However, many patients present with circulating blasts at diagnosis, raising the possibility of using peripheral blood as an alternative source for initial immunophenotypic classification. Although previous studies have shown that peripheral blood can support initial diagnostic classification, they have not determined the degree of marker-level concordance between peripheral blood and bone marrow nor the clinical conditions under which this concordance is strongest. In this study, we evaluated the immunophenotypic concordance between peripheral blood and bone marrow in 32 pediatric patients with B-cell acute lymphoblastic leukemia, using paired samples obtained at diagnosis and analyzed with a standardized panel of B-lineage and maturation markers. Accordingly, the objective of this study was to quantify marker-specific agreement between compartments and identify clinical factors associated with higher concordance. Overall concordance was moderate across all subpopulations (mean CCC ~0.63) but higher for the markers most relevant to routine diagnostic classification (e.g., CD19+, CD10+, CD34+, and HLA-DR+), several of which exceeded 95% concordance and showed minimal bias between specimens. These findings apply only to newly diagnosed B-ALL with sufficient circulating blasts, as cases with minimal residual disease, low-blast presentations, atypical immunophenotypes, or mixed-lineage leukemias were not included in this study. The greatest concordance was seen in patients with hemoglobin < 8 g/dL, in whom extensive marrow infiltration promotes blast spillover into circulation. Likewise, patients older than 10 years showed high concordance, consistent with greater leukemic burden at presentation. Even in subgroups with lower circulating blast levels, such as those with hemoglobin ≥ 8 g/dL, peripheral blood adequately reproduced most leukemic cell populations present in bone marrow. Overall, these findings indicate that the markers and subpopulations most relevant for diagnostic immunophenotyping can be reliably assessed using peripheral blood in high-burden disease settings, reducing the immediate need for invasive procedures and facilitating timely immunophenotypic classification, particularly in resource-limited environments or situations where rapid initiation of treatment is critical.

15 October 2024 in Revista Científica de la Facultad de Ciencias Veterinarias
Verified
Journal Article
Open access
PDF file
NDNayelli Delgado–Arellano
Nayelli Delgado–Arellano
ACALBERTO DANIEL SAUCEDO CAMPOS
ALBERTO DANIEL SAUCEDO CAMPOS
LMLiborio Martínez–Cruz
Liborio Martínez–Cruz
JTJuan Del Toro–Herrera
Juan Del Toro–Herrera
JHJosé Bernardo Hernández–Jiménez
José Bernardo Hernández–Jiménez
La Ehrlichiosis canina es una enfermedad infecciosa transmitida por garrapatas, producida por Ehrlichia spp., se encuentra distribuida a nivel mundial, con mayor frecuencia en regiones tropicales y subtropicales, presentando incremento de casos entre abril y septiembre debido a la mayor incidencia de garrapatas. Ehrlichia spp. son microorganismos intracelulares obligados que infectan leucocitos, tienden a incrustarse en el citoplasma de células sanguíneas en mórulas. Se presentó un caso clínico de una hembra canina, con antecedentes de garrapata y signos clínicos de anemia. En el hemograma se encontró anemia y trombocitopenia. En frotis sanguíneo se observaron mórulas basofílicas en neutrófilos, hallazgos compatibles con Ehrlichia spp. Se realizó la prueba de SNAP 4Dx® (IDEXX) la cual confirmo el diagnóstico de Ehrlichiosis. Se administró a la paciente Doxiciclina durante 30 días en total y otros fármacos. El tratamiento con Doxiciclina fue satisfactorio, porque la paciente se recuperó después de 30 días de tratamiento.

24 October 2024 in Cancers
Verified
Journal Article
Open access
PDF file
MCMyriam Campos-Aguilar
Myriam Campos-Aguilar
WTWilfrido David Tapia-Sánchez
Wilfrido David Tapia-Sánchez
ACALBERTO DANIEL SAUCEDO CAMPOS
ALBERTO DANIEL SAUCEDO CAMPOS
CDCarlos Leonardo Duarte-Martínez
Carlos Leonardo Duarte-Martínez
SOSandra Olivas-Quintero
Sandra Olivas-Quintero
APAlberto Ponciano-Gómez
Alberto Ponciano-Gómez
Background/Objectives: B-cell acute lymphoblastic leukemia (B-ALL) presents a challenge in hematological malignancies due to its heterogeneity, which impacts treatment outcomes. Stratification based on the DNA index (DNAi) categorizes patients into favorable prognosis (hyperploid), standard prognosis (normoploid), and uncertain or poor prognosis (hypoploid) groups. In this study, we explored whether specific immunophenotypic markers are associated with each DNAi-based group and their potential connection to prognostic categories, aiming to provide new insights that may contribute to a better understanding of prognosis in B-ALL. Methods: In this study, we utilized flow cytometry to analyze immunophenotypic markers and combined this with DNA index (DNAi) measurements to stratify pediatric B-ALL patients into distinct risk categories. Our methodology focused on accurately classifying patients into hyperploid, normoploid, and hypoploid groups based on their DNA content, facilitating a comparative analysis of immunophenotypic characteristics across these groups. Results: Our analysis revealed that hypoploid B-ALL patients displayed a significantly lower percentage of cells in the S phase of the cell cycle compared to normoploid and hyperploid groups. Additionally, distinct immunophenotypic profiles were observed in hypoploid patients, characterized by higher expression levels of HLA-DR and a notable co-expression of CD34 and CD22. Conclusions: This study found that hypoploid B-ALL patients have distinct characteristics, such as lower S-phase cell percentages and specific immunophenotypic profiles, including higher HLA-DR expression and CD34/CD22 co-expression. These differences across DNA index-based prognostic categories warrant further research to explore their potential prognostic significance.